Experimental Base
In 2017, BIolink Supply Chain (Beijing) Ltd. was established in Beijing Tianzhu Comprehensive Free Trade Zone, committed to providing efficient foreign trade, business, logistics integration services for multinational biological companies. Our customers include scientific research, biopharmaceutical, CRO, CDMO, blood products, etc. Europa undertakes the distribution of WHO global influenza vaccine production strains and quality control standards in China, which is the core source of influenza vaccine production and quality control. It is also the service provider of ATCC (American Standard Biological Products Collection Center) in China, and the foreign trade, business and logistics service provider of BD, Sartoris, Cytiva, Danaher and many other international famous brands in China.
In 2019, the construction of the Greenland Free port Laboratory, located in tianzhu Free Trade Zone, was started. The laboratory is built in accordance with the current domestic GMP standards, with the overall cleanliness level of the core functional areas reaching ten thousand, and local cleanliness level reaching 100, which can support the cultivation scale of human diploid cells, stem cells and other mammalian cells from research and development to production. The laboratory is also equipped with AKTA protein purification apparatus, electrophoresis apparatus, ultra-micro spectrophotometer and other detection equipment, which can realize cell culture, separation, concentration, purification, preparation, preservation and detection and identification of downstream products, providing hardware basis for life science, in vitro diagnosis and research and development of biopharmaceuticals related products.
Based on the national biological industry development plan, BIoulik will deepen the development of service trade, constantly meet the biological industry's demand for high-quality products and professional services, and provide a strong guarantee for the development and production of biological industry. The development direction of P2 laboratory includes the establishment of cell recovery bank, large-scale stem cell culture, and complete purification and identification functions. Based on this, we will develop our own products and provide incubation services in the field of cell products and regenerative medicine. We will continue to expand more areas of cooperation with foreign partners with advanced and cutting-edge technologies, and integrate more new products and technologies into more optimized solutions to promote to our customers. At the same time, it can also provide more professional training, technical consultation, product display, after-sales support and a series of services.
